RetSat Knockout Mitigates Hypoxia-Induced Microglial Activation by Enhancing Lipid Droplets Degradation

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Hypoxic environments can cause neurological dysfunction.
• Microglia-derived neuroinflammation is implicated in hypoxia-induced neuronal impairment, but mechanisms are unclear.
• Lipid-droplet-accumulating microglia (LDAM) are linked to neurodegeneration, suggesting a role in hypoxia.

Purpose of the Study:

• To investigate the role of lipid metabolism in microglia during hypoxia.
• To explore RETSAT as a key regulator of lipid accumulation in microglia under hypoxic conditions.
• To assess the therapeutic potential of targeting RETSAT in hypoxia-induced neuroinflammation.

Main Methods:

• Investigated hypoxia-induced changes in microglia.
• Analyzed lipid droplet accumulation and RETSAT levels in microglia.
• Utilized conditional knockout of RETSAT in microglia (in vitro and in vivo).
• Assessed neuroinflammation and oxidative stress markers.
• Examined the role of hormone-sensitive lipase (HSL) and RETSAT mutation Q247R.

Main Results:

• Hypoxia induced lipid droplet accumulation in microglia, associated with increased RETSAT.
• Conditional knockout of RETSAT in microglia reduced lipid droplets, neuroinflammation, and oxidative stress.
• RETSAT knockout enhanced lipid droplet degradation via increased HSL activity.
• The RETSAT Q247R mutation promoted microglia lipolysis under hypoxia.

Conclusions:

• RETSAT plays a critical role in regulating lipid metabolism in microglia during hypoxia.
• Targeting RETSAT can alleviate hypoxia-induced microglial activation, neuroinflammation, and oxidative stress.
• RETSAT represents a potential therapeutic target for conditions involving hypoxia-induced neurological impairment.